Blog
Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.
Page 12
Semaglutide vs Tirzepatide Heart Risks
A critical letter followed a large semaglutide-versus-tirzepatide target trial emulation. Here is what the observational evidence can and cannot show.
Semaglutide vs Tirzepatide in FAERS
A 2026 FAERS analysis found different reporting patterns for semaglutide and tirzepatide, without establishing comparative risk or causality.
Semaglutide in Very Old Adults
A matched study linked semaglutide to better daily function and heart-failure health status in adults aged 80 or older, without proving causation.
TB-500 Side Effects: Evidence Limits
TB-500 has no validated human safety profile, late-stage trials or regulatory label, so precise adverse-event rates cannot be stated responsibly.
TB-500 and WADA: What Athletes Need
TB-500 is prohibited at all times under WADA's S2 growth-factor framework, including through named-example and related-substance wording.
CJC-1295 Explained
CJC-1295 is an experimental long-acting GHRH analogue studied for its effects on growth hormone and IGF-1 in healthy adults.
CJC-1295 status in Denmark
CJC-1295 has no verified Danish medicine route. The 2026 import change did not approve it and doping-agent restrictions still matter.
Importing ipamorelin into Denmark
Denmark permits some personal medicine imports, but ipamorelin raises doping-agent rules, prescription proof and source-country legality.
Ipamorelin cost in Denmark
No official Danish ipamorelin pharmacy price or routine reimbursement could be verified because no authorised pack was identified.
Ipamorelin status in Denmark
Denmark has no verified authorised ipamorelin medicine route. The 2026 import reform did not create an approval or pharmacy product.
Importing PT-141 into Denmark
A US Vyleesi prescription product and a grey-market PT-141 vial are different legal objects under Denmark personal-import rules.
What One Myocarditis Report Cannot Prove
One account cannot prove that a peptide caused myocarditis. It can, however, highlight why possible cardiac-emergency symptoms need urgent assessment.